Scientific Technology Company Regains Nasdaq Compliance

The resurgence of Applied DNA is emblematic of its broader strategic vision and commitment to innovation.

Applied DNA Sciences, Inc. (NASDAQ:APDN), a front-runner in the innovative field of PCR-based DNA technologies, marks a significant turnaround in its corporate narrative with the recent announcement that it has regained compliance with the Nasdaq Minimum Bid Price Requirement. This development on May 9, 2024, not only underscores the company's resilienc…